Results 31 to 40 of about 32,569 (155)
Anemia in Lymphoproliferative Disorders [PDF]
Cancer Control, 1998 The onset of anemia in patients with lymphoproliferative disorders can be attributed to various causes, including autoimmune hemolytic anemia, pure red cell aplasia, and anemia of chronic disease. A variety of interventions can provide benefit.
openaire +2 more sources
Клиническая онкогематология, 2018 In recent years increasing attention focuses on the concept of EBV-positive lymphoproliferative diseases related to primary or secondary immunodeficiency resulting from immunosuppressive therapy and persistent infections. Due to the progress of treatment
Alla Mikhailovna Kovrigina
doaj +1 more source
PLoS ONE, 2021 Flow cytometry immunophenotyping has an essential role in distinguishing chronic lymphocytic leukemia from other B-chronic lymphoproliferative disorders. Recently, CD200 is considered as a relatively consistent marker in chronic lymphocytic leukemia.
Sana Dlawar Jalal
doaj +1 more source
Challenges and opportunities for checkpoint blockade in T-cell lymphoproliferative disorders
Journal for ImmunoTherapy of Cancer, 2016 The T-cell lymphoproliferative disorders are a heterogeneous group of non-Hodgkin’s lymphomas (NHL) for which current therapeutic strategies are inadequate, as most patients afflicted with these NHL will succumb to disease progression within 2 years of ...
Tycel Phillips +2 more
doaj +1 more source
Haematologica, 2020 Indolent T-cell lymphoproliferative disorders of the gastrointestinal tract are rare clonal T-cell diseases that more commonly occur in the intestines and have a protracted clinical course.
Craig R. Soderquist +15 more
doaj +1 more source
Russian Open Medical Journal, 2020 The article is dedicated to contemporary views on the change of endothelial function in the patients with lymphoproliferative disorders prior to, and in the process of, chemotherapeutic treatment. Considering that possibilities of standard examination do
Igor L. Davydkin +7 more
doaj +1 more source
Haematologica, 2016 Epstein-Barr virus-related post-transplant lymphoproliferative disorders are recognized as a significant cause of morbidity and mortality in patients undergoing hematopoietic stem cell transplantation.
Jan Styczynski +6 more
doaj +1 more source
Autoimmune Hemolytic Anemia as Presenting Symptom of Hodgkin Lymphoma
Case Reports in Hematology, 2021 Autoimmune hemolytic anemia (AIHA) is related to an underlying condition in an estimated 50 to 60%, while the remaining is idiopathic, as a result of a combination of immune activation, deficiency, or dysregulation.
Nicholas B. Burley +5 more
doaj +1 more source
ERJ Open Research, 2020 Introduction Malignant lymphoproliferative disorders are rarely observed in the lung and, considering their clinical and radiological heterogeneity, diagnosis is often difficult and may require invasive methods.
Rita Bianchi +10 more
doaj +1 more source
EXPRESSION OF A NEW A3 ANTIGEN IN THE CELLS OF PATIENTS WITH VARIOUS LYMPHOPROLIFERATIVE DISEASES
Медицинская иммунология, 2014 We have conducted a study of a novel monoclonal A3 antibody raised by means of hybridoma biotechnology. The study was performed with malignant cells of the patients with various lymphoproliferative disorders, and persons with nonmalignant diseases, as ...
N. L. Deineko +3 more
doaj +1 more source